Cover Image

COMPUTATION DESIGN OF QUINAZOLINE-4(3H)-ON DERIVATIVES AS CYCLOOXYGENASE-2 (COX-2) INHIBITOR

The 3-(benzylideneamino)-2-(2,4-dichlorophenyl)-quinazoline-4(3H)-ones (BDCQ) are compounds developed as anticancer drugs and quinazolines. The activity and bioavailability of BDCQ derivatives as anticancer compounds that inhibit COX-2 can be predicted by computer programs and online servers. Substi...

Full description

Saved in:

Bibliographic Details
Main Author:	Anita Puspa Widiyana (Author)
Format:	Book
Published:	Universitas Muhammadiyah Magelang, 2021-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Design and Molecular Docking Studies of Quinazoline Derivatives as Antiproliferation
by: Anita Puspa Widiyana, et al.
Published: (2018)

Design and biological evaluation of 3-substituted quinazoline-2,4(1H,3H)-dione derivatives as dual c-Met/VEGFR-2-TK inhibitors
by: Abdelfattah Hassan, et al.
Published: (2023)

Cyclooxygenase (COX) Inhibitors and the Newborn Kidney
by: Wei Qi, et al.
Published: (2012)

Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
by: Harris RE, et al.
Published: (2012)

Design, Synthesis, Pharmacological Evaluation of Quinazolin-4(3H)-Ones Bearing Urea Functionality as Potential VEGFR-2 Inhibitors
by: Al-Sanea MM, et al.
Published: (2024)

Synthesis and antitumor activity of certain 2,3,6-trisubstituted quinazolin-4(3H)-one derivatives
by: Safinaz E. Abbas, et al.
Published: (2013)

Design, synthesis, molecular modeling and biological evaluation of novel diaryl heterocyclic analogs as potential selective cyclooxygenase-2 (COX-2) inhibitors
by: Deema A. Al-Turki, et al.
Published: (2017)

Design of more potent quinazoline derivatives as EGFRWT inhibitors for the treatment of NSCLC: a computational approach
by: Muhammad Tukur Ibrahim, et al.
Published: (2021)

Chiral Derivatives of Xanthones: Investigation of the Effect of Enantioselectivity on Inhibition of Cyclooxygenases (COX-1 and COX-2) and Binding Interaction with Human Serum Albumin
by: Carla Fernandes, et al.
Published: (2017)

Synthesis and cytotoxic evaluation of some new 3-(2-(2-phenylthiazol-4-yl) ethyl)-quinazolin-4(3H) one derivatives with potential anticancer effects
by: Leila Hosseinzadeh, et al.
Published: (2017)

Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature
by: Alessandra Pannunzio, et al.
Published: (2018)

Synthesis and Biological Evaluation of Some New 3-Aryl-2-thioxo-2,3-dihydroquinazolin-4(1<i>H</i>)-ones and 3-Aryl-2-(benzylthio)quinazolin-4(3<i>H</i>)-ones as Antioxidants; COX-2, LDHA, α-Glucosidase and α-Amylase Inhibitors; and Anti-Colon Carcinoma and Apoptosis-Inducing Agents
by: Nahed Nasser Eid El-Sayed, et al.
Published: (2023)

Design, synthesis, molecular docking and anticonvulsant evaluation of novel 6-iodo-2-phenyl-3-substituted-quinazolin-4(3H)-ones
by: Mohamed-Kamal Ibrahim, et al.
Published: (2015)

Quinazolin-4(3H)-one based potential multiple tyrosine kinase inhibitors with excellent cytotoxicity
by: Tebyan O. Mirgany, et al.
Published: (2021)

Design, Synthesis and Biological Evaluation of New 5,5-Diarylhydantoin Derivatives as Selective Cyclooxygenase-2 Inhibitors
by: Afshin ZARGHI, et al.
Published: (2011)

Design, Synthesis and molecular docking study of hybrids of quinazolin-4(3H)-one as anticancer agents
by: Sukanya Nara, et al.

Benzo[g]quinazolin-based scaffold derivatives as dual EGFR/HER2 inhibitors
by: Mostafa M. Ghorab, et al.
Published: (2018)

The study of UV-spectra of the sodium (3-oxo-3,4-dihydro-2H-[1,2,4]triazino[4,3-c]quinazolin-4-yl)acetate
by: О. V. Kryvoshey
Published: (2016)

Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory Potentialities
by: Noor ul Amin Mohsin, et al.
Published: (2022)

Synthesis of New 3-Substituted Quinazolin-4(3H)-one Compounds Via Linking of Some Five-Membered Ring Heterocyclic Moieties With Quinazolin-4(3H)-one Nucleus
by: Mohammed Al-iraqi, et al.
Published: (2021)

Flavocoxid Inhibits Phospholipase A2, Peroxidase Moieties of the Cyclooxygenases (COX), and 5-Lipoxygenase, Modifies COX-2 Gene Expression, and Acts as an Antioxidant
by: Bruce P. Burnett, et al.
Published: (2011)

Design, synthesis, and biological study of 4-[(2-nitroimidazole-1H-alkyloxyl)aniline]-quinazolines as EGFR inhibitors exerting cytotoxicities both under normoxia and hypoxia
by: Cheng W, et al.
Published: (2019)

Cyclooxygenase (COX)-2 as a potent molecular target for prevention and therapy of oral cancer
by: Masahiro Urade
Published: (2008)

Cyclooxygenase-2 inhibitors: promise or peril?
by: Laurel J. Mengle-Gaw, et al.
Published: (2002)

Development of (4-Phenylamino)quinazoline Alkylthiourea Derivatives as Novel NF-κB Inhibitors
by: Sarah S. Darwish, et al.
Published: (2022)

Synthesis and anti-microbial screening of novel schiff bases of 3-amino-2-methyl quinazolin 4-(3H)-one
by: Govindaraj Saravanan, et al.
Published: (2010)

Synthesis and evaluation of anticancer, antiphospholipases, antiproteases, and antimetabolic syndrome activities of some 3H-quinazolin-4-one derivatives
by: Nahed N. E. El-Sayed, et al.
Published: (2019)

Antioxidant and Cytotoxic Activity of New Polyphenolic Derivatives of Quinazolin-4(3H)-one: Synthesis and In Vitro Activities Evaluation
by: Raluca Pele, et al.
Published: (2022)

Actoprotective activity of 6-monosubstituted 3-R-6,7-dihydro-2H-[1,2,4]triazino-[2,3-c]quinazoline-2-ones
by: O. S. Kolomoets, et al.
Published: (2016)

SYNTHESIS AND ANTIMICROBIAL EVALUATION OF 2-[(SUBSTITUEDPHENYL)-5-(1-PHENYL-3-(PIPERAZINYL)PYRIDO[3,2-f]QUINAZOLIN-4(1H)-YL]-1,3,4-THIADIAZOLES
by: Ranjana Dubey, et al.
Published: (2016)

A sulfonimide derivative of bezafibrate as a dual inhibitor of cyclooxygenase-2 and PPARα
by: Alessandra Ammazzalorso, et al.
Published: (2024)

Quinazolinone and Quinazoline Derivatives
Published: (2020)

Effects of the estrous cycle, pregnancy and interferon tau on expression of cyclooxygenase two (COX-2) in ovine endometrium
by: Bazer Fuller W, et al.
Published: (2003)

Design, synthesis, molecular docking, and molecular dynamic studies of novel quinazoline derivatives as phosphodiesterase 7 inhibitors
by: Afaf A. El-Malah, et al.
Published: (2024)

Introduction of pyrrolidineoxy or piperidineamino group at the 4-position of quinazoline leading to novel quinazoline-based phosphoinositide 3-kinase delta (PI3Kδ) inhibitors
by: Minhang Xin, et al.
Published: (2018)

TXNIP inhibition in the treatment of type 2 diabetes mellitus: design, synthesis, and biological evaluation of quinazoline derivatives
by: Aiyun Li, et al.
Published: (2023)

Design, synthesis, and antiprotozoal evaluation of new 2,4-bis[(substituted-aminomethyl)phenyl]quinoline, 1,3-bis[(substituted-aminomethyl)phenyl]isoquinoline and 2,4-bis[(substituted-aminomethyl)phenyl]quinazoline derivatives
by: Jean Guillon, et al.
Published: (2020)

Synthesis, characterization, cytotoxic screening, and density functional theory studies of new derivatives of quinazolin-4(3H)-one Schiff bases
by: Rezvan Rezaee Nasab, et al.
Published: (2017)

Pulmonary and Cardiorenal Cyclooxygenase-1 (COX-1), -2 (COX-2), and Microsomal Prostaglandin E Synthase-1 (mPGES-1) and -2 (mPGES-2) Expression in a Hypertension Model
by: Zaher A. Radi, et al.
Published: (2007)

Synthesis and Biological Evaluation of Gentiopicroside Derivatives as Novel Cyclooxygenase-2 Inhibitors with Anti-Inflammatory Activity
by: Ren G, et al.
Published: (2023)